During this unprecedented time, the faculty of CVNUK has unsurprisingly decided to postpone this year’s event. As such it will no longer be held on FRIDAY 12th JUNE 2020 but don’t worry, all registrations will automatically transfer to the new date:
FRIDAY 27th November 2020
Once again the conference will be held within the beautiful surroundings of the Wolfson College, Oxford, and we look forward to seeing everybody there where we will no doubt have lots to discuss and debate.
Please see below for the current programme.
Abstract submissions for the 2020 conference are now open.
Please download the instructions below to find out how to submit an abstract.
Entries will close on Sunday 13th November 2020.
If there are any queries relating to abstract submission please contact Andy Cockayne at Page Medical on 01353 780060.
The UK Clinical Vaccine Network Conference provides the perfect opportunity for industry leaders to showcase their products and services to others within the UK vaccine community, as well as the chance to discuss both UK vaccine research and future research directions. With dedicated networking opportunities and an engaging and interactive exhibition hall, this is a fantastic opportunity for sponsors who wish to join us for this exciting new event.
The idea of the conference is for the UK Clinical Vaccine Network to engage with industry as real partners in this event and will offer delegate passes alongside sponsorship to encourage debate and interaction from academic, clinical and commercial side.
We have a number of sponsorship packages available to suit individual company needs.
For more information please contact Debbie Cockayne at firstname.lastname@example.org or +44 (0) 7763731054.
REGISTRATION – FOR THE 2020 CONFERENCE IS NOW OPEN
Following the success of the UK Clinical Vaccine Network Conference 2019, there is now a FREE forum for all involved in vaccine development and use, to debate current issues and share knowledge, resources and ideas. Click on the link below to join discussions with other like-minded people within the vaccine community.